| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operations Officer | Chief Operating Officer
1 company
Dagnon Terry is a Chief Operations Officer at Outlook Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 3 sells.
Estimated insider holdings value: $1.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2023 | OTLK Outlook Therapeutics, Inc. | Chief Operations Officer | Sell | 520,000 | $1.14 | $590,200.00 | -44.3% | +49.6% | -65.7% | |
| Jun 21, 2022 | OTLK Outlook Therapeutics, Inc. | Chief Operating Officer | Buy | 10,000 | $1.05 | $10,500.00 | +0.9% | +20.0% | +66.7% | |
| Dec 6, 2021 | OTLK Outlook Therapeutics, Inc. | Chief Operating Officer | Buy | 25,201 | $1.38 | $34,777.38 | +2.2% | +34.3% | -26.3% | |
| Dec 3, 2021 | OTLK Outlook Therapeutics, Inc. | Chief Operating Officer | Buy | 10,000 | $1.42 | $14,200.00 | +0.9% | +34.6% | -18.8% | |
| Feb 23, 2021 | OTLK Outlook Therapeutics, Inc. | Chief Operating Officer | Sell | 15,900 | $2.09 | $33,199.20 | -1.4% | - | - | |
| Feb 12, 2021 | OTLK Outlook Therapeutics, Inc. | Chief Operating Officer | Sell | 63,700 | $2.55 | $162,435.00 | -5.3% | - | - |